Concepedia

Zayani Sims

ZS

Statistics

Publications

10

Citations

970

H-Index

10

Active since

2014

Affiliations

Gilead Sciences (United States)(Current)

National Institute of Allergy and Infectious Diseases

University of Maryland, Baltimore

National Institutes of Health

National Institutes of Health Clinical Center

Zayani Sims is an author at Gilead Sciences (United States) specializing in viral hepatitis, antiviral therapy, and infectious diseases.

Publications per year

2014–2016

10

Publications

10

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

, , +17

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study

Anita Kohli, Rama Kapoor, Zayani Sims et al. · The Lancet Infectious Diseases · 2015 · 167 citations · Full text

, , +14

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

Eric G. Meissner, Y.-J. Lee, Anu Osinusi et al. · Hepatology · 2014 · 158 citations · Full text

, , +17

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +16

Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

Sreetha Sidharthan, Anita Kohli, Zayani Sims et al. · Clinical Infectious Diseases · 2015 · 101 citations · Full text

, , +17

1–5 of 10